Anticarbamylated protein antibodies can be detected in animal models of arthritis that require active involvement of the adaptive immune system

Annals of the Rheumatic Diseases

Volumn 74, Issue 5, 2015, Pages 949-950

  Stoop, Jeroen N ^a   Fischer, Anita ^b   Hayer, Silvia ^b   Hegen, Martin ^c   Huizinga, Tom W J ^a   Steiner, Guenter ^b,d   Trouw, Leendert A ^a   Toes, René E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c PFIZER INC   (United States)

^d Ludwig Boltzmann Cluster for Rheumatology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HOMOCITRULLINE; ISOCYANATE; LYSINE; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR; AUTOANTIBODY; CARBAMIC ACID DERIVATIVE; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRALGIA; ARTHRITIS; CARBAMOYLATION; DISEASE COURSE; HUMAN; LETTER; MEDICAL RESEARCH; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; RAT;

ADAPTIVE IMMUNITY; ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; CARBAMATES; DISEASE MODELS, ANIMAL; MICE; PEPTIDES, CYCLIC; PROTEINS; RATS;

EID: 84926686349     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206797     Document Type: Letter

References (10)

1. Willemze A, Trouw LA, Toes RE, et al. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol 2012;8:144-52.
2. Shi J, van Veelen PA, Mahler M, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev 2014;13:225-30.
3. Shi J, Knevel R, Suwannalai P, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA 2011;108:17372-7.
4. Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum 2013;65:911-15.
5. Kuhn KA, Kulik L, Tomooka B, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
6. Vossenaar ER, Nijenhuis S, Helsen MM, et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003;48:2489-500.
7. Stoop JN, Liu BS, Shi J, et al. Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. PloS ONE 2014;9:e102163.
8. Hayer S, Tohidast-Akrad M, Haralambous S, et al. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice. J Immunol 2005;175:8327-36.
9. Hoffmann MH, Tuncel J, Skriner K, et al. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis. J Immunol 2007;179:7568-76.
10. Hegen M, Keith JC Jr, Collins M, et al. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008;67:1505-15.